Biography:
Dr. Luo received her PhD in Molecular Biology in 2011 at University of Miami. After four years postdoctoral fellowship at the same institute, he then joined Shanghai General Hospital as researcher at Department of Ophthalmology. After five years, Dr. Luo moved to pharmaceutical industry and worked at different companies with increasing roles and responsibilities. Currently, he served as VP of Discovery at UgeneX Biotechnology, focusing on developing innovative gene therapy for ophthalmology diseases. Dr. Luo has published more than 50 research articles in SCI journals.
Title : Preclinical evaluation of optogenetic therapy by clinically relevant multi-luminance behavioral test